Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Mixing and Homogenization of Elixir Components – V 2.0

Posted on By

Elixir Department: SOP for Mixing and Homogenization of Elixir Components – V 2.0

Standard Operating Procedure for Mixing and Homogenization of Elixir Components

Department Elixir Department
SOP No. SOP/ELX/054/2025
Supersedes SOP/ELX/054/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standard procedure for the uniform mixing and homogenization of all ingredients in elixir formulations to ensure product consistency and compliance with quality standards.

2. Scope

This SOP is applicable to all batches of elixirs manufactured in the Elixir Department using fixed or variable speed agitators, inline homogenizers, or other mixing equipment.

3. Responsibilities

  • Manufacturing Operator:
    • Perform mixing operations as per the instructions outlined in the BMR.
    • Ensure equipment is set up and operated correctly.
  • Production Supervisor:
    • Verify mixing time, speed, and completion.
  • QA Officer:
    • Monitor and record in-process checks, including homogeneity tests.
See also  Elixir Department: SOP for Sampling of Raw Materials for Elixirs - V 2.0

4. Accountability

The Production Head is accountable for ensuring that mixing and homogenization activities are conducted as per validated procedures and documented accurately.

5. Procedure

5.1 Equipment Preparation

  1. Ensure the manufacturing tank or mixing vessel is clean
and ready as per SOP/ELX/051/2025.
  • Verify agitator blades and homogenizer components are intact and properly assembled.
  • Check calibration status of speed controller (if applicable).
  • 5.2 Mixing Operation

    1. Start agitator at low speed (e.g., 30–40 RPM) for initial dispersion of components.
    2. Gradually increase to the required speed as per the BMR (typically 60–150 RPM).
    3. Continue mixing for the specified time (e.g., 30–60 minutes), ensuring uniformity.
    4. For high-viscosity mixtures or multi-phase systems, initiate inline or mechanical homogenization as per instructions.
    5. Record start and end times in the Mixing Log (Annexure-1).

    5.3 Homogenization Steps

    1. Transfer the batch through an inline homogenizer (if applicable) operating at recommended pressure (e.g., 100–150 bar).
    2. Alternatively, recirculate the batch through the homogenization loop until desired consistency is achieved.
    3. Perform in-process homogeneity check (see Annexure-2).

    5.4 Precautions

    1. Do not exceed the maximum agitation speed defined for the equipment.
    2. Avoid vigorous agitation of volatile or alcohol-based formulations to minimize evaporation and foaming.
    3. Ensure batch temperature is within limits during mixing (as specified in BMR).

    5.5 Documentation

    1. Fill out the Mixing and Homogenization Log (Annexure-1).
    2. Attach process observations and results of homogeneity check.

    6. Abbreviations

    • BMR: Batch Manufacturing Record
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • RPM: Revolutions Per Minute

    7. Documents

    1. Mixing and Homogenization Log (Annexure-1)
    2. Homogeneity Check Record (Annexure-2)
    3. Equipment Verification Log (Annexure-3)

    8. References

    • WHO TRS 961 Annex 3 – GMP for Liquid Oral Preparations
    • ICH Q8 – Pharmaceutical Development

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Mixing and Homogenization Log

    Date Batch No. Start Time End Time RPM Mixed By Verified By
    11/04/2025 ELX-1001 09:30 AM 10:15 AM 120 Rajesh Kumar Sunita Reddy

    Annexure-2: Homogeneity Check Record

    Sample Point Time Appearance Assay Result Status Checked By
    Top 10:20 AM Clear 98.5% Pass Sunita Reddy
    Middle 10:21 AM Clear 98.7% Pass Sunita Reddy
    Bottom 10:22 AM Clear 98.6% Pass Sunita Reddy

    Annexure-3: Equipment Verification Log

    Date Equipment ID Agitator Status Verified By
    11/04/2025 MX-TNK-05 Operational Manju Sharma

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New Document QA Head
    11/04/2025 2.0 Included Homogenization Section and Annexures Process Control Enhancement QA Head
    See also  Elixir Department: SOP for Controlled Substance Dispensing for Elixirs - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: Development of Assay Methods using Classical Techniques – V 2.0
    Next Post: API Manufacturing: SOP for Verification of IPC Equipment Status – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version